Medical specialists from France tagged as investigators in clinical trials studying Severe Acute Respiratory Syndrome

Total 122 results

Adeline BAUVOIS, MD
Seen in:
- Boulogne-Billancourt, Hopital Ambroise Pare
Trials:
- NCT04863547 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Agnès Lefort, MD
Seen in:
- Clichy, Hopital Beaujon
Trials:
- NCT04863547 (Sub-Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Albert Trinh-Duc
Seen in:
- Agen, CH Agen-Nérac
Trials:
- NCT04885452 (Principal Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection
Amélie Chabrol, MD
Seen in:
- Corbeil-Essonnes, Centre hopsitalier Sud Francilien
- Corbeil-essonnes, Hôpital Sud Francilien
Trials:
- NCT04863547 (Principal Investigator)
- NCT04658329 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2);
- HIV-2 Infection
Amélie DUREAULT, MD
Seen in:
- Valence, Centre Hospitalier de Valence
Trials:
- NCT04863547 (Sub-Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
André CABIE
Seen in:
- Fort-de-France, CHU de Martinique
Trials:
- NCT04885452 (Principal Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection
Anne-Marie Ronchetti
Seen in:
- Corbeil-Essonnes, Centre Hospitalier Sud Francilien - Hématologie
Trials:
- NCT04885452 (Principal Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection
Anthony Chauvin
Seen in:
- Paris, Hôpital Lariboisière - SAU SMUR
- Paris, Lariboisière University Hospital - APHP
Trials:
- NCT04885452 (Principal Investigator)
- NCT04148495 (Principal Investigator)
Conditions:
Audrey Le Bot
Seen in:
- Rennes, CHU de Rennes
Trials:
- NCT04885452 (Principal Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection
Aurélie Martin
Seen in:
- Nîmes, CHU de Nimes
Trials:
- NCT04885452 (Principal Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection
Aurélie PORTEFAIX, MD,PhD
Seen in:
- Bron, Hôpital Louis Pradel
Trials:
- NCT04376476 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2;
- Infection, Coronavirus
Aurélien Dihn, MD
Seen in:
- Garches, Hôpital de Garches
Trials:
- NCT04863547 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Benjamin Davido, MD
Seen in:
- Garches, Hôpital de Garches
Trials:
- NCT04863547 (Sub-Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Benjamin LEFEVRE
Seen in:
- Nancy, CHRU de Nancy
- Nancy, CHU Nancy - Hôpital Brabois
Trials:
- NCT04885452 (Principal Investigator)
- NCT02898987 (Principal Investigator)
- NCT03795376 (Principal Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection;
- HIV;
- HIV Prevention
Benjamin Terrier
Seen in:
- Paris, GSK Investigational Site
- Paris, Hôpitaux Cochin - Port Royal
Trials:
- NCT05263934 (Principal Investigator)
- NCT04885452 (Principal Investigator)
Conditions:
Benjamin Wilpoz, MD
Seen in:
- Le Kremlin-Bicêtre, Hopital Kremlin Bicetre
Trials:
- NCT04863547 (Sub-Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Cécile Ficko, MD
Seen in:
- Saint-Mandé, Hopital d'Instruction des Armees BEGIN
Trials:
- NCT04863547 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Cécile Goujard
Seen in:
- Le Kremlin-Bicêtre, Hôpital Bicêtre - HdJ - Médecine interne
- Le Kremlin-Bicêtre, Hôpital Bicêtre - Médecine interne
- Le Kremlin-Bicêtre, Hôpital Bicêtre APHP
Trials:
- NCT04885452 (Principal Investigator)
- NCT05149001 (Principal Investigator)
- NCT05300035 (Principal Investigator)
Conditions:
Charlotte Cordonnier, MD,PhD
Seen in:
- Lille, CHU Lille
- Lille, Hôpital Roger Salengro, CHU Lille
Trials:
- NCT04889326 (Principal Investigator)
- NCT04583800 (Principal Investigator)
Conditions:
Christèle GRAS-LE-GUEN, PU,PH
Seen in:
- Nantes, Hôpital mère - enfant Nantes
Trials:
- NCT04376476 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2;
- Infection, Coronavirus
Christophe Billy, MD
Seen in:
- Mantes-la-Jolie, Centre Hospitalier François Quesnay
Trials:
- NCT04863547 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Christophe Choquet
Seen in:
- Paris, Hôpital Bichat Claude-Bernard - SAU
Trials:
- NCT04885452 (Principal Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection
Christophe RAPP, MD
Seen in:
- Neuilly-sur-Seine, American Hospital of Paris
Trials:
- NCT04863547 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Claire Andrejak, MD
Seen in:
- Amiens, CHU Amiens Picardie site Nord
Trials:
- NCT04863547 (Sub-Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Claudine TOUBOUL
Seen in:
- Creteil, Centre Hospitalier Intercommunal
Trials:
- NCT04863547 (Sub-Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Clémence JARRASSE, MD,PhD
Seen in:
- Épagny, Centre Hospitalier D'Annecy-Genevois
Trials:
- NCT04376476 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2;
- Infection, Coronavirus
Cyrille CONFAVREUX, PU,PH
Seen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud
Trials:
- NCT04376476 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2;
- Infection, Coronavirus
David CHIRIO, MD
Seen in:
- Nice, CHU de NICE - Infectiologie
Trials:
- NCT04779021 (Sub-Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection
Delphine FEYEUX, MD
Seen in:
- Paris, Groupe Hospitalier Diaconesses Croix Saint-Simon
Trials:
- NCT04863547 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Diane Ponscarme, MD
Seen in:
- Paris, Hôpital Saint louis
Trials:
- NCT04863547 (Sub-Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Clinical Trials on Severe Acute Respiratory Syndrome

Assistance Publique - Hôpitaux de Paris

Completed

Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS (STROMA-CoV2)

Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Distress Syndrome

France
Oneness Biotech Co., Ltd.

Completed

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)

United States
NeuroActiva, Inc.

Unknown

Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831 (NEUROSIVIR)

Severe Acute Respiratory Syndrome | Covid19 | Corona Virus Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia | Neurodegeneration | Neuroinflammatory Response | Severe Acute Respiratory Infection | Severe Acute Respiratory Syndrome of Upper Respiratory Tract

United States
Hôpital Universitaire Sahloul

Completed

Quercetin In The Treatment Of SARS-COV 2 (QUERCOV)

SARS (Severe Acute Respiratory Syndrome)

Tunisia
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; National Institute... and other collaborators

Completed

Sisonke (Together): OPEN LABEL TRIAL COVID-19 (Sisonke)

SARS (Severe Acute Respiratory Syndrome)

South Africa
Throne Biotechnologies Inc.

Not yet recruiting

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Severe Acute Respiratory Syndrome (SARS) Pneumonia
Laboratorios Silanes S.A. de C.V.

Completed

Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. (DMMETCOV19-2)

Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Takeda

Completed

A Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

Japan
Massachusetts General Hospital
Xijing Hospital; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Niguarda...

Completed

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 (NOSARSCOVID)

Coronavirus | SARS (Severe Acute Respiratory Syndrome)

United States, Sweden
Pulmoquine Therapeutics, Inc
Rockefeller University

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers

Severe Acute Respiratory Syndrome Coronavirus 2

United States

Medical specialists from France tagged as investigators in clinical trials studying Severe Acute Respiratory Syndrome

Clinical Trials on Severe Acute Respiratory Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations